Pharsight Makes Strong Contribution to Inaugural American Conference on Pharm...( Pharsight Scientists Will Present at ...)

Pharsight Scientists Will Present at First Joint U.S. National Modeling and

Simulation Meeting on March 11-12, 2008

MOUNTAIN VIEW, Calif., Mar. 4 /PRNewswire-FirstCall/ -- Pharsight Corporation (Nasdaq: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced its broad-based participation at the inaugural meeting of the American Conference on Pharmacometrics (ACoP). Pharsight scientists will make a total of 10 scientific contributions at this groundbreaking event, which will be held in Tucson, Arizona at the Westward Look Resort from March 9-12, 2008.

"This meeting illustrates the impact of pharmacometrics on the drug development process," said Shawn O'Connor, president, CEO, and chairman of Pharsight. "Pharmacometrics has been recognized by the FDA for improving new drug approval and labeling decisions, and academia and industry have responded by adding significant numbers to their staff in this area. We are delighted to recognize the significant growth of this profession by sponsoring its first, dedicated national conference."

Pharsight scientists will present on a range of modeling and simulation subject areas, such as drug-disease modeling, clinical utility modeling, and state-of-the-art tools and techniques, during two plenary conference sessions and at three focused poster sessions, including:
-- Model-Based Literature Meta-Analysis: Virtues and Limitations. Dr.

Farkad Ezzet, senior scientist, Strategic Consulting Services, will

present as part of a dedicated conference session on altering disease

progression. Dr. Ezzet's presentation will outline how model-based

'/>"/>